S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
BREAKING: Tiny biotech successfully treats blindness (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds a major oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
BREAKING: Tiny biotech successfully treats blindness (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds a major oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
BREAKING: Tiny biotech successfully treats blindness (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds a major oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Stock market today: Asian shares mixed as Japan business confidence rises and US shutdown is averted
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Federal student loan payments are starting again. Here's what you need to know
Bank of Japan survey shows manufacturers optimistic about economy
BREAKING: Tiny biotech successfully treats blindness (Ad)
Facing increasing pressure from customers, some miners are switching to renewable energy
Grant program for Black women entrepreneurs blocked by federal appeals court
Watch SHOCKING Footage of AI Facility with Ties to Elon Musk (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
The UAE holds a major oil and gas conference just ahead of hosting UN COP28 climate talks in Dubai
NASDAQ:PTGX

Protagonist Therapeutics (PTGX) News Today

$16.68
-0.45 (-2.63%)
(As of 09/29/2023 08:53 PM ET)
Compare
Today's Range
$16.33
$17.31
50-Day Range
$16.68
$20.37
52-Week Range
$7.24
$30.10
Volume
1.39 million shs
Average Volume
1.21 million shs
Market Capitalization
$959.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$37.00
SourceHeadline
MarketBeat logoProtagonist Therapeutics (NASDAQ:PTGX) Cut to "Sell" at StockNews.com
americanbankingnews.com - September 30 at 3:20 AM
marketbeat.com logoProtagonist Therapeutics (NASDAQ:PTGX) Lowered to "Sell" at StockNews.com
marketbeat.com - September 30 at 3:18 AM
MarketBeat logoProtagonist Therapeutics (NASDAQ:PTGX) Price Target Cut to $34.00 by Analysts at JPMorgan Chase & Co.
americanbankingnews.com - September 26 at 3:40 AM
MarketBeat logoProtagonist Therapeutics (NASDAQ:PTGX) Trading Down 3.9% on Analyst Downgrade
americanbankingnews.com - September 26 at 1:32 AM
msn.com logoJP Morgan Maintains Protagonist Therapeutics (PTGX) Overweight Recommendation
msn.com - September 26 at 12:54 AM
marketbeat.com logoProtagonist Therapeutics (NASDAQ:PTGX) Price Target Lowered to $34.00 at JPMorgan Chase & Co.
marketbeat.com - September 25 at 7:52 AM
MarketBeat logoProtagonist Therapeutics (NASDAQ:PTGX) Rating Increased to Hold at StockNews.com
americanbankingnews.com - September 24 at 1:42 AM
marketbeat.com logoProtagonist Therapeutics (NASDAQ:PTGX) Lifted to Hold at StockNews.com
marketbeat.com - September 23 at 12:12 AM
marketbeat.com logo41,818 Shares in Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Bought by Financial Enhancement Group LLC
marketbeat.com - September 13 at 5:04 AM
marketbeat.com logoBVF Inc. IL Buys Shares of 3,775,900 Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
marketbeat.com - September 12 at 4:39 AM
finance.yahoo.com logoProtagonist Therapeutics to Present at Upcoming Investor Conferences
finance.yahoo.com - September 5 at 9:23 AM
marketbeat.com logoProtagonist Therapeutics, Inc. (NASDAQ:PTGX) Shares Sold by Russell Investments Group Ltd.
marketbeat.com - August 27 at 4:16 AM
marketbeat.com logoFederated Hermes Inc. Has $682,000 Stock Holdings in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
marketbeat.com - August 22 at 4:38 AM
marketbeat.com logoConnor Clark & Lunn Investment Management Ltd. Sells 72,680 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
marketbeat.com - August 21 at 5:54 AM
marketbeat.com logoGreat Lakes Advisors LLC Makes New $3.46 Million Investment in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
marketbeat.com - August 20 at 5:50 AM
marketbeat.com logoProtagonist Therapeutics (NASDAQ:PTGX) Receives New Coverage from Analysts at StockNews.com
marketbeat.com - August 17 at 3:32 AM
finanznachrichten.de logoProtagonist Therapeutics, Inc.: Protagonist Receives $34 Million from Warrant Exercises
finanznachrichten.de - August 9 at 10:17 AM
finance.yahoo.com logoProtagonist Receives $34 Million from Warrant Exercises
finance.yahoo.com - August 9 at 10:17 AM
marketbeat.com logoProtagonist Therapeutics, Inc. (NASDAQ:PTGX) Shares Acquired by Barclays PLC
marketbeat.com - August 8 at 6:11 AM
markets.businessinsider.com logoAnalysts Are Bullish on These Healthcare Stocks: Protagonist Therapeutics (PTGX), Dynavax (DVAX)
markets.businessinsider.com - August 4 at 7:26 PM
marketbeat.com logoHC Wainwright Reaffirms Buy Rating for Protagonist Therapeutics (NASDAQ:PTGX)
marketbeat.com - August 4 at 11:01 AM
finanznachrichten.de logoProtagonist Therapeutics, Inc.: Protagonist Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - August 3 at 6:06 PM
finance.yahoo.com logoProtagonist Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 3 at 6:06 PM
finance.yahoo.com logoPTGX - Protagonist Therapeutics, Inc.
finance.yahoo.com - July 22 at 5:22 PM
marketbeat.com logo17,285 Shares in Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Acquired by CM Wealth Advisors LLC
marketbeat.com - July 21 at 7:29 AM
marketbeat.com logoMackenzie Financial Corp Buys Shares of 27,504 Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
marketbeat.com - July 20 at 4:30 AM
finanznachrichten.de logoProtagonist Therapeutics, Inc.: Protagonist Therapeutics Reports Granting of Inducement Award
finanznachrichten.de - July 18 at 7:13 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and KalVista Pharmaceuticals (KALV)
markets.businessinsider.com - July 10 at 8:20 AM
msn.com logoJMP Securities Maintains Protagonist Therapeutics (PTGX) Market Outperform Recommendation
msn.com - July 6 at 5:45 PM
msn.com logoExpert Ratings for Protagonist Therapeutics
msn.com - July 6 at 5:45 PM
markets.businessinsider.com logoAnalyst Boosts Protagonist Therapeutics Price Target, Says Psoriasis Data Impressive
markets.businessinsider.com - July 6 at 5:45 PM
markets.businessinsider.com logoJMP Securities Sticks to Their Buy Rating for Protagonist Therapeutics (PTGX)
markets.businessinsider.com - July 5 at 8:34 PM
finance.yahoo.com logoProtagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment
finance.yahoo.com - July 5 at 10:33 AM
marketbeat.com logoProtagonist Therapeutics, Inc. (NASDAQ:PTGX) Holdings Boosted by Allspring Global Investments Holdings LLC
marketbeat.com - July 5 at 4:23 AM
msn.com logoPiper Sandler Reiterates Protagonist Therapeutics (PTGX) Overweight Recommendation
msn.com - July 4 at 5:37 PM
msn.com logoBTIG Reiterates Protagonist Therapeutics (PTGX) Buy Recommendation
msn.com - July 4 at 5:37 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Protagonist Therapeutics (PTGX) and Arcus Biosciences (RCUS)
markets.businessinsider.com - July 4 at 7:30 AM
finance.yahoo.com logoProtagonist Therapeutics Announces Positive Topline Results with JNJ-2113, the First and Only Oral IL-23 Receptor Antagonist Peptide in Development for Moderate-to-Severe Plaque Psoriasis
finance.yahoo.com - July 4 at 7:30 AM
fool.com logoProtagonist Therapeutics (NASDAQ: PTGX)
fool.com - July 3 at 3:00 PM
benzinga.com logoAstraZeneca, ECARX Holdings And Other Big Stocks Moving Lower On Monday
benzinga.com - July 3 at 11:03 AM
marketbeat.com logo
marketbeat.com - July 3 at 9:37 AM
finance.yahoo.com logoProtagonist Therapeutics (PTGX) Is a Great Choice for 'Trend' Investors, Here's Why
finance.yahoo.com - June 30 at 1:06 PM
marketbeat.com logoGratus Capital LLC Has $4.87 Million Stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
marketbeat.com - June 30 at 12:45 PM
marketbeat.com logoAre (More) Big Gains Ahead for This Small Cap Biotech Stock? (PTGX)
marketbeat.com - June 28 at 8:57 AM
msn.com logoWall Street Analysts Predict a 25.35% Upside in Protagonist Therapeutics (PTGX): Here's What You Should Know
msn.com - June 15 at 2:30 PM
finance.yahoo.com logoWall Street Analysts Predict a 25.35% Upside in Protagonist Therapeutics (PTGX): Here's What You Should Know
finance.yahoo.com - June 15 at 2:30 PM
finance.yahoo.com logoHere's Why Momentum in Protagonist Therapeutics (PTGX) Should Keep going
finance.yahoo.com - June 13 at 5:21 PM
finance.yahoo.com logoClinical Response and Durability of Response of Rusfertide (PTG-300) in Polycythemia Vera Featured Today at EHA Press Briefing; Protagonist Therapeutics Plans a Follow-on Two-Year Extension Study to Enable Further Evaluation of the Long-Term Effects of Rusfertide in PV
finance.yahoo.com - June 9 at 12:49 PM
finance.yahoo.com logoProtagonist Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at 2023 European Hematology Association (EHA) Congress
finance.yahoo.com - June 6 at 9:32 AM
marketbeat.com logoUBS Group AG Increases Position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
marketbeat.com - June 4 at 4:30 AM
Get Protagonist Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTGX and its competitors with MarketBeat's FREE daily newsletter.



PTGX Media Mentions By Week

PTGX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PTGX
News Sentiment

-0.26

0.69

Average
Medical
News Sentiment

PTGX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PTGX Articles
This Week

8

2

PTGX Articles
Average Week

Get Protagonist Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTGX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PTGX) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -